Rchr
J-GLOBAL ID:200901079006454678   Update date: Nov. 14, 2024

Hiroaki Hidekazu

ヒロアキ ヒデカズ | Hiroaki Hidekazu
Affiliation and department:
Job title: 教授
Homepage URL  (1): http://presat-vector.org/hiroaki-lab/
Research field  (3): Pharmaceuticals - analytical and physicochemistry ,  Pharmaceuticals - chemistry and drug development ,  Biophysics
Research theme for competitive and other funds  (19):
  • 2024 - 2027 PDZ足場タンパク質の機能に介入する阻害剤ライブラリの構築と創薬応用
  • 2017 - 2020 Propagation of Alzheimer's disease neuronal cell death by intracellular formation and secretion of abnormal aggregates
  • 2015 - 2018 Development of NMR drug discovery pipeline using database
  • 2014 - 2017 Elucidation of a neurodegenerative mechanism induced by a new Alzheimer's disease drug target and its inhibition
  • 2016 - 2017 Application of molecular shielding effect of intrinsically disordered proteins towards development of protein stabilizers
Show all
Papers (104):
  • Koya Miura, Youichi Suzuki, Kotaro Ishida, Masashi Arakawa, Hong Wu, Yoshihiko Fujioka, Akino Emi, Koki Maeda, Ryusei Hamajima, Takashi Nakano, et al. Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells. Journal of virology. 2023. 97. 10. e0042623
  • Yuri Emoto, Ryoya Katayama, Emi Hibino, Sho Ishihara, Natsuko Goda, Takeshi Tenno, Yoshihiro Kobashigawa, Hiroshi Morioka, Hidekazu Hiroaki. A Cost-Effective Immobilization Method for MBP Fusion Proteins on Microtiter Plates Using a Gelatinized Starch-Agarose Mixture and Its Application for Convenient Protein-Protein Interaction Analysis. Methods and Protocols. 2023. 6. 3. 44-44
  • Mio Nakashima, Natsuko Goda, Takeshi Tenno, Ayaka Kotake, Yuko Inotsume, Minako Amaya, Hidekazu Hiroaki. Pharmacologic Comparison of High-Dose Hesperetin and Quercetin on MDCK II Cell Viability, Tight Junction Integrity, and Cell Shape. Antioxidants (Basel, Switzerland). 2023. 12. 4
  • Takamasa Mizoguchi, Shohei Mikami, Mari Yatou, Yui Kondo, Shuhei Omaru, Shuhei Kuwabara, Wataru Okura, Syouta Noda, Takeshi Tenno, Hidekazu Hiroaki, et al. Small-Molecule-Mediated Suppression of BMP Signaling by Selective Inhibition of BMP1-Dependent Chordin Cleavage. International journal of molecular sciences. 2023. 24. 5
  • Hidekazu Hiroaki. Molecular mechanisms of amyloid-β peptide fibril and oligomer formation: NMR-based challenges. Biophysics and physicobiology. 2023. 20. 1. e200007
more...
MISC (65):
  • Hidekazu Hiroaki. Drug Discovery by Targeting Intrinsically Disordered Proteins - Potential and Challenges. MedChem News. 2022. 32. 3. 136-139
  • Hidekazu Hiroaki. Perspective for epitherial barrier enhancement by modulating homeostasis of tight junction. FRAGRANCE JOURNAL. 2022. 50. 5. 34-41
  • Hidekazu HIROAKI. Insights into the Mechanisms of Oligomerization/Fibrilization of Amyloid β Peptide from Nuclear Magnetic Resonance. Seibutsu Butsuri. 2022. 62. 1. 39-42
  • 廣明 秀一. 【構造生命科学による創薬への挑戦】計算機から創薬へ 天然変性タンパク質と創薬. 医学のあゆみ. 2021. 278. 6. 653-662
  • 廣明秀一, 天野剛志. Rational Drug Discovery for Inhibiting Ubiquitination of Magnesium Channels. ソルト・サイエンス研究財団助成研究報告集 2 医学 食品科学編. 2021. 2019
more...
Patents (19):
Books (3):
  • All aspects of phase separation biology
    2020 ISBN:9784807913466
  • The handbool for protein experiments
    2011 ISBN:9784758101790
  • タンパク質の立体構造入門 : 基礎から構造バイオインフォマティクスへ
    講談社 2010 ISBN:9784061538818
Lectures and oral presentations  (151):
  • Development of drugs targeting the interaction between the SARS-CoV-2 envelope and host PDZ-containing proteins
    (日本ウイルス学会学術集会プログラム・予稿集(Web) 2021)
  • Usefulness and cautionary points of post-synthetic modification of oligonucleotides by click
    (日本核酸医薬学会年会講演要旨集(CD-ROM) 2021)
  • Analysis of Pharmacological Effects of Dvl Inhibitors on Triple Negative Breast Cancer Cells
    (日本分子生物学会年会プログラム・要旨集(Web) 2021)
  • A construction of useful binding assay for interactions PDZ domain and carboxy-terminal tail by using microtiter plates
    (日本分子生物学会年会プログラム・要旨集(Web) 2021)
  • The role of E protein on the formation of SARS-CoV-2 Virus-Like Particle
    (日本分子生物学会年会プログラム・要旨集(Web) 2021)
more...
Education (3):
  • 1989 - 1992 Osaka University Graduate School, Division of Pharmaceutical Sciences
  • 1987 - 1989 Osaka University Graduate School, Division of Pharmaceutical Sciences
  • 1984 - 1987 Osaka University Faculty of Pharmaceutical Science
Professional career (3):
  • 薬学士 (大阪大学)
  • 薬学修士 (大阪大学)
  • 博士(薬学) (大阪大学)
Work history (11):
  • 2021/04 - 現在 Nagoya University Graduare School of Pharmaceutical Sciences Dean
  • 2012/04 - 現在 Nagoya University Graduare School of Pharmaceutical Sciences Proffesor
  • 2013/04 - 2023/03 Nagoya University Cellular and Structural Physiology Institute Director in General
  • 2015/04 - 2021/03 Nagoya University AIP Depuity of Director in General
  • 2015/04 - 2019/03 Nagoya University Division of Human Resource Development Business Capacity Development Center Director in General
Show all
Association Membership(s) (7):
American Association for the Advancement of Science ,  日本分子生物学会 ,  日本ケミカルバイオロジー学会 ,  日本生物物理学会 ,  日本蛋白質科学会 ,  日本核磁気共鳴学会 ,  日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page